NVZMF
Novozymes A/S
Price Chart
Latest Quote
$58.29
-0.44 (-0.75%)
Current Price
| Previous Close | $58.73 |
| Open | $60.00 |
| Day High | $60.00 |
| Day Low | $60.00 |
| Volume | 300 |
Stock Information
Note: Financial values converted from EUR to USD
| Quarterly Dividend / Yield | $1.01 / 1.73% |
| Shares Outstanding | 412.48M |
| Quarterly Dividend Yield | 1.73% |
| Quarterly Dividend | $1.01 |
| Total Debt | $3.68B |
| Cash Equivalents | $375.27M |
| Revenue | $4.82B |
| Net Income | $684.37M |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Market Cap | $27.18B |
| P/E Ratio | 39.12 |
| EPS (TTM) | $1.49 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $29.88B |
| Sales | $4.82B |
| Income | $684.37M |
| Book/sh | $27.36 |
| Cash/sh | $0.79 |
| Employees | 11K |
Financial Ratios
| Quick Ratio | 1.02 |
| Current Ratio | 1.67 |
| Debt/Eq | 29.42 |
| EPS Growth TTM | 7.00% |
Returns & Margins
| ROA | 3.80% |
| ROE | 5.39% |
| Gross Margin | 55.86% |
| Operating Margin | 24.42% |
| Profit Margin | 14.21% |
Ownership
| Insider Ownership | 15.81% |
| Institutional Ownership | 35.81% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 31.68 |
| PEG | 1.95 |
| P/S | 6.47 |
| P/B | 2.13 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $58.26 |
| SMA50 | $59.01 |
| SMA200 | $59.98 |
| RSI | 60.63 |
| ATR | 1.2821 |
| Shares Float | 344.43M |
| Volatility | 0.62 |
| Rel Volume | 1.76 |
Performance History
| Week | -2.98% |
| Month | +4.20% |
| Quarter | +11.86% |
| 6 Months | -1.68% |
| YTD | -4.56% |
| Year | -18.65% |
| 3 Years | +27.58% |
| 5 Years | -17.55% |
| 10 Years | +48.77% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $58.29 | 5,600 |
| 2026-06-17 | $58.73 | 46,100 |
| 2026-06-16 | $57.26 | 400 |
| 2026-06-15 | $59.20 | 100 |
| 2026-06-12 | $59.86 | 700 |
| 2026-06-11 | $60.08 | 0 |
| 2026-06-10 | $60.08 | 700 |
| 2026-06-09 | $58.92 | 100 |
| 2026-06-08 | $56.36 | 1,000 |
| 2026-06-05 | $57.78 | 0 |
| 2026-06-04 | $57.78 | 200 |
| 2026-06-03 | $57.50 | 100 |
| 2026-06-02 | $57.71 | 0 |
| 2026-06-01 | $57.71 | 100 |
| 2026-05-29 | $55.65 | 100 |
| 2026-05-28 | $57.92 | 200 |
| 2026-05-27 | $60.70 | 200 |
| 2026-05-26 | $58.17 | 1,500 |
| 2026-05-22 | $59.60 | 6,500 |
| 2026-05-21 | $55.94 | 0 |
| 2026-05-20 | $55.94 | 0 |
| 2026-05-19 | $55.94 | 0 |
About Novozymes A/S
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricultural and industrial residues and food waste; biomass; carbon capture; ethanol for liquefaction, saccharification, fermentation, and fiber conversion; and renewable diesel. In addition, it provides dishwashing, home cleaning, laundry, medical, and industrial and institutional cleaning services; gastrointestinal, immune, mental, women's, children's cardiometabolic, and oral human health solutions. Further, the company offers corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; silage, diary and beef cattle, poultry, swine, aquaculture solutions; pet care solutions; leather and textiles solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions; and distilling, oils and fats, sustainable plastic solutions. Additionally, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S is headquartered in Lyngby, Denmark.
đ° Latest News
FUL or NVZMY: Which Is the Better Value Stock Right Now?
Zacks âĸ 2026-06-19T15:40:04Z
A Look At Novozymes (CPSE:NSIS B) Valuation After Recent Share Price Weakness
Simply Wall St. âĸ 2026-05-14T00:29:10Z
FUL vs. NVZMY: Which Stock Should Value Investors Buy Now?
Zacks âĸ 2026-04-16T15:40:02Z
Novozymes Dividend Increase And Valuation Discount Catch Investor Attention
Simply Wall St. âĸ 2026-04-04T14:07:55Z
Novonesis (Novozymes) B (NVZMF) Full Year 2025 Earnings Call Highlights: Strong Organic Sales ...
GuruFocus.com âĸ 2026-02-25T15:01:10ZIs Novozymes (CPSE:NSIS B) Pricing Reflect Recent Valuation Concerns Accurately
Simply Wall St. âĸ 2026-02-16T05:05:24Z
Cabot Expands Mexico Footprint With MXCB Facility Buyout
Zacks âĸ 2026-02-05T14:21:00Z
CENX's Hawesville Site Sale to Facilitate AI Data Campus Buildout
Zacks âĸ 2026-02-04T12:40:00Z
NVZMY vs. HWKN: Which Stock Is the Better Value Option?
Zacks âĸ 2026-02-03T16:40:02Z
CF & POET Partner to Advance Low-Carbon Pathway for U.S. Ethanol
Zacks âĸ 2026-01-27T13:01:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $2,024,000,000 | $1,097,400,000 | $1,070,473,127 | $850,849,273 |
| Cost Of Revenue | $2,024,000,000 | $1,097,400,000 | $1,070,473,127 | $850,849,273 |
| Total Revenue | $3,833,500,000 | $2,402,200,000 | $2,355,819,308 | $2,010,279,310 |
| Operating Revenue | $3,833,500,000 | $2,402,200,000 | $2,355,819,308 | $2,010,279,310 |
| Expenses | ||||
| Interest Expense | $76,400,000 | $23,100,000 | $13,689,601 | $13,714,701 |
| Total Expenses | $3,174,500,000 | $1,791,300,000 | $1,761,529,563 | $1,487,910,564 |
| Net Non Operating Interest Income Expense | $-61,000,000 | $-20,000,000 | $-24,560,755 | $-13,983,616 |
| Total Other Finance Cost | $11,500,000 | $8,900,000 | $13,286,966 | $2,689,157 |
| Interest Expense Non Operating | $76,400,000 | $23,100,000 | $13,689,601 | $13,714,701 |
| Operating Expense | $1,150,500,000 | $693,900,000 | $691,056,436 | $637,061,292 |
| Selling And Marketing Expense | $550,900,000 | $317,400,000 | $304,794,944 | $260,310,397 |
| General And Administrative Expense | $214,600,000 | $128,700,000 | $127,769,611 | $115,499,293 |
| Other Non Operating Income Expenses | - | - | $39,189,839 | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $305,800,000 | $405,900,000 | $493,362,489 | $423,004,395 |
| Net Interest Income | $-61,000,000 | $-20,000,000 | $-24,560,755 | $-13,983,616 |
| Interest Income | $26,900,000 | $12,000,000 | $2,415,812 | $2,420,241 |
| Normalized Income | $427,917,800 | $452,310,577 | $449,815,636 | $390,943,659 |
| Net Income From Continuing And Discontinued Operation | $305,800,000 | $405,900,000 | $493,362,489 | $423,004,395 |
| Total Operating Income As Reported | $659,000,000 | $610,900,000 | $621,266,312 | $538,772,604 |
| Net Income Common Stockholders | $305,800,000 | $405,900,000 | $493,362,489 | $423,004,395 |
| Net Income | $305,800,000 | $405,900,000 | $493,362,489 | $423,004,395 |
| Net Income Including Noncontrolling Interests | $305,800,000 | $407,900,000 | $494,704,607 | $422,869,937 |
| Net Income Continuous Operations | $305,800,000 | $407,900,000 | $494,704,607 | $422,869,937 |
| Pretax Income | $417,100,000 | $524,700,000 | $611,468,852 | $527,612,602 |
| Special Income Charges | $-158,000,000 | $-55,200,000 | $47,779,392 | $24,740,244 |
| Interest Income Non Operating | $26,900,000 | $12,000,000 | $2,415,812 | $2,420,241 |
| Operating Income | $659,000,000 | $610,900,000 | $594,289,745 | $522,368,746 |
| Gross Profit | $1,809,500,000 | $1,304,800,000 | $1,285,346,181 | $1,159,430,038 |
| Per Share | ||||
| Diluted EPS | $0.67 | $1.46 | $1.77 | $1.51 |
| Basic EPS | $0.67 | $1.47 | $1.78 | $1.52 |
| Other | ||||
| Tax Effect Of Unusual Items | $-44,482,200 | $-13,289,423 | $1,145,668 | $881,437 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $1,204,200,000 | $793,900,000 | $776,012,490 | $693,130,215 |
| Total Unusual Items | $-166,600,000 | $-59,700,000 | $44,692,521 | $32,942,173 |
| Total Unusual Items Excluding Goodwill | $-166,600,000 | $-59,700,000 | $44,692,521 | $32,942,173 |
| Reconciled Depreciation | $544,100,000 | $186,400,000 | $195,546,558 | $184,745,085 |
| EBITDA (Bullshit earnings) | $1,037,600,000 | $734,200,000 | $820,705,012 | $726,072,388 |
| EBIT | $493,500,000 | $547,800,000 | $625,158,454 | $541,327,303 |
| Diluted Average Shares | $459,604,953 | $277,874,971 | $278,733,918 | $280,228,105 |
| Basic Average Shares | $457,624,227 | $277,035,068 | $276,644,153 | $277,919,162 |
| Diluted NI Availto Com Stockholders | $305,800,000 | $405,900,000 | $493,362,489 | $423,004,395 |
| Otherunder Preferred Stock Dividend | $0 | $0 | $0 | $0 |
| Minority Interests | $0 | $-2,000,000 | $-1,342,118 | $134,458 |
| Tax Provision | $111,300,000 | $116,800,000 | $116,764,245 | $104,742,665 |
| Other Special Charges | $-12,700,000 | $4,000,000 | $-17,850,166 | $-16,403,858 |
| Write Off | $22,300,000 | $0 | - | - |
| Impairment Of Capital Assets | $34,500,000 | $0 | - | - |
| Restructuring And Mergern Acquisition | $113,900,000 | $51,200,000 | $-47,779,392 | $-8,336,387 |
| Research And Development | $413,200,000 | $270,700,000 | $268,557,764 | $270,125,820 |
| Selling General And Administration | $765,500,000 | $446,100,000 | $432,564,555 | $375,809,690 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $1,151,800,000 | $1,267,600,000 | $1,226,561,423 | $914,716,751 |
| Total Assets | $15,195,600,000 | $3,809,400,000 | $3,755,648,134 | $3,330,117,563 |
| Total Non Current Assets | $13,316,200,000 | $2,539,900,000 | $2,515,397,110 | $2,278,253,805 |
| Non Current Deferred Taxes Assets | $275,000,000 | $236,400,000 | $217,825,713 | $220,107,500 |
| Investmentin Financial Assets | $18,700,000 | $8,300,000 | $12,347,483 | $4,033,735 |
| Goodwill And Other Intangible Assets | $10,024,200,000 | $608,000,000 | $630,526,925 | $675,516,237 |
| Other Intangible Assets | $4,419,200,000 | $343,000,000 | $361,163,890 | $403,911,380 |
| Current Assets | $1,879,400,000 | $1,269,500,000 | $1,240,251,024 | $1,051,863,758 |
| Assets Held For Sale Current | $11,600,000 | $44,500,000 | $0 | $0 |
| Inventory | $720,600,000 | $486,700,000 | $510,407,385 | $402,297,886 |
| Other Receivables | $139,000,000 | $46,800,000 | $68,582,218 | $75,161,938 |
| Taxes Receivable | $58,600,000 | $39,700,000 | $47,242,545 | $38,454,945 |
| Accounts Receivable | $665,600,000 | $496,700,000 | $463,567,475 | $396,381,741 |
| Allowance For Doubtful Accounts Receivable | $-21,100,000 | $-19,800,000 | $-18,252,802 | $-20,303,135 |
| Gross Accounts Receivable | $686,700,000 | $516,500,000 | $481,820,277 | $416,684,876 |
| Cash Cash Equivalents And Short Term Investments | $284,000,000 | $155,100,000 | $150,451,401 | $139,567,248 |
| Cash And Cash Equivalents | $280,000,000 | $149,700,000 | $139,714,459 | $129,482,909 |
| Debt | ||||
| Net Debt | $1,516,800,000 | $839,200,924 | $724,206,744 | $637,733,581 |
| Total Debt | $1,796,800,000 | $1,038,658,890 | $919,082,244 | $832,025,174 |
| Long Term Debt And Capital Lease Obligation | $1,530,400,000 | $612,476,987 | $524,365,410 | $542,806,339 |
| Long Term Debt | $1,530,400,000 | $581,315,877 | $485,712,418 | $494,401,513 |
| Current Debt And Capital Lease Obligation | $266,400,000 | $426,181,903 | $394,716,834 | $289,218,835 |
| Current Debt | $266,400,000 | $407,780,731 | $378,208,785 | $272,814,977 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $4,019,600,000 | $1,883,800,000 | $1,846,082,982 | $1,688,925,050 |
| Total Non Current Liabilities Net Minority Interest | $2,931,300,000 | $911,100,000 | $911,566,384 | $926,145,669 |
| Non Current Deferred Taxes Liabilities | $1,255,900,000 | $263,600,000 | $221,852,066 | $179,770,145 |
| Current Liabilities | $1,088,300,000 | $972,700,000 | $934,516,598 | $762,779,381 |
| Other Current Liabilities | $315,100,000 | $290,500,000 | $21,205,461 | - |
| Payables | $484,000,000 | $241,500,000 | $482,357,124 | $417,760,539 |
| Total Tax Payable | $60,900,000 | $24,600,000 | $43,753,039 | $65,346,515 |
| Accounts Payable | $423,100,000 | $216,900,000 | $250,841,810 | $200,342,196 |
| Derivative Product Liabilities | - | $134,315 | $0 | $403,374 |
| Other Payable | - | $192,473,579 | $187,762,275 | $152,071,828 |
| Other Non Current Liabilities | - | - | $30,063,438 | $73,010,612 |
| Equity | ||||
| Common Stock Equity | $11,176,000,000 | $1,875,600,000 | $1,857,088,348 | $1,590,232,988 |
| Total Equity Gross Minority Interest | $11,176,000,000 | $1,925,600,000 | $1,909,565,152 | $1,641,192,513 |
| Stockholders Equity | $11,176,000,000 | $1,875,600,000 | $1,857,088,348 | $1,590,232,988 |
| Retained Earnings | $11,032,400,000 | $1,845,600,000 | $1,753,074,221 | $1,519,777,075 |
| Long Term Equity Investment | $24,000,000 | $27,500,000 | $29,929,226 | $3,899,278 |
| Other | ||||
| Treasury Shares Number | $2,162,857 | $3,682,554 | $4,401,011 | $4,894,362 |
| Ordinary Shares Number | $466,135,789 | $277,317,446 | $276,598,989 | $277,105,638 |
| Share Issued | $468,298,646 | $281,000,000 | $281,000,000 | $282,000,000 |
| Tangible Book Value | $1,151,800,000 | $1,267,600,000 | $1,226,561,423 | $914,716,751 |
| Invested Capital | $11,176,000,000 | $1,875,600,000 | $2,721,009,551 | $2,357,449,478 |
| Working Capital | $791,100,000 | $296,800,000 | $305,734,426 | $289,084,377 |
| Total Capitalization | $11,176,000,000 | $1,875,600,000 | $2,342,800,766 | $2,084,634,501 |
| Minority Interest | $0 | $50,000,000 | $52,476,805 | $50,959,525 |
| Capital Stock | $125,600,000 | $75,400,000 | $75,427,018 | $75,834,227 |
| Common Stock | $125,600,000 | $75,400,000 | $75,427,018 | $75,834,227 |
| Non Current Deferred Revenue | $105,300,000 | $20,400,000 | $17,313,319 | $13,176,869 |
| Long Term Provisions | $39,700,000 | $15,100,000 | $15,971,201 | $20,572,051 |
| Available For Sale Securities | $18,700,000 | $8,300,000 | $12,347,483 | $4,033,735 |
| Investmentsin Associatesat Cost | $24,000,000 | $27,500,000 | $29,929,226 | $3,899,278 |
| Goodwill | $5,605,000,000 | $265,000,000 | $269,363,035 | $271,604,856 |
| Net PPE | $2,968,300,000 | $1,653,800,000 | $1,620,472,986 | $1,369,453,199 |
| Accumulated Depreciation | $-2,038,300,000 | $-1,864,200,000 | $-1,848,901,429 | $-1,733,968,429 |
| Gross PPE | $5,006,600,000 | $3,518,000,000 | $3,469,374,415 | $3,103,421,628 |
| Construction In Progress | $619,800,000 | $237,000,000 | $388,677,304 | $117,785,076 |
| Other Properties | $481,500,000 | $388,600,000 | $386,529,916 | $362,498,363 |
| Machinery Furniture Equipment | $2,213,500,000 | $1,772,200,000 | $1,659,260,189 | $1,607,846,966 |
| Properties | $1,691,800,000 | $1,120,200,000 | $1,034,907,006 | $1,015,291,223 |
| Finished Goods | $357,000,000 | $250,900,000 | $250,573,386 | $212,443,402 |
| Work In Process | $255,200,000 | $176,000,000 | $178,904,298 | $131,634,235 |
| Raw Materials | $108,400,000 | $59,800,000 | $80,929,701 | $58,220,249 |
| Other Short Term Investments | $4,000,000 | $5,400,000 | $10,736,942 | $10,084,339 |
| Capital Lease Obligations | - | $49,562,282 | $55,161,040 | $64,808,684 |
| Long Term Capital Lease Obligation | - | $31,161,110 | $38,652,992 | $48,404,826 |
| Current Capital Lease Obligation | - | $18,401,173 | $16,508,048 | $16,403,858 |
| Pensionand Other Post Retirement Benefit Plans Current | - | $3,089,248 | $2,818,447 | $5,916,145 |
| Current Provisions | - | $1,611,782 | $1,342,118 | $2,823,615 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $660,100,000 | $281,300,000 | $149,780,342 | $379,440,052 |
| Operating Activities | ||||
| Operating Cash Flow | $1,019,900,000 | $557,100,000 | $537,652,376 | $546,167,785 |
| Investing Activities | ||||
| Capital Expenditure | $-359,800,000 | $-275,800,000 | $-387,872,033 | $-166,727,734 |
| Investing Cash Flow | $-199,700,000 | $-286,200,000 | $-358,613,866 | $-369,355,713 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $37,800,000 | $22,400,000 | $22,010,731 | $41,547,476 |
| Financing Cash Flow | $-703,200,000 | $-253,500,000 | $-167,764,720 | $-213,250,150 |
| Net Other Financing Charges | $-85,900,000 | - | - | - |
| Cash Dividends Paid | $-249,800,000 | $-383,200,000 | $-204,672,959 | $-197,115,208 |
| Common Stock Dividend Paid | $-249,800,000 | $-383,200,000 | - | - |
| Net Common Stock Issuance | $37,800,000 | $22,400,000 | $-45,095,157 | $-160,139,299 |
| Common Stock Issuance | $37,800,000 | $22,400,000 | $22,010,731 | $41,547,476 |
| Repurchase Of Capital Stock | - | $0 | $-67,105,888 | $-201,686,775 |
| Other | ||||
| Repayment Of Debt | $-539,800,000 | $-334,700,000 | $-215,007,266 | $-172,509,421 |
| Issuance Of Debt | $134,500,000 | $442,000,000 | $287,213,201 | $288,277,630 |
| End Cash Position | $280,000,000 | $149,700,000 | $139,714,459 | $129,482,909 |
| Beginning Cash Position | $149,700,000 | $139,700,000 | $129,245,941 | $158,794,720 |
| Effect Of Exchange Rate Changes | $13,300,000 | $-7,400,000 | $-805,271 | $7,126,266 |
| Changes In Cash | $117,000,000 | $17,400,000 | $11,273,789 | $-36,438,077 |
| Net Issuance Payments Of Debt | $-405,300,000 | $107,300,000 | $98,108,808 | $157,853,516 |
| Net Long Term Debt Issuance | $-405,300,000 | $107,300,000 | $72,205,936 | $115,768,209 |
| Long Term Debt Payments | $-539,800,000 | $-334,700,000 | $-215,007,266 | $-172,509,421 |
| Long Term Debt Issuance | $134,500,000 | $442,000,000 | $287,213,201 | $288,277,630 |
| Net Business Purchase And Sale | $159,300,000 | $-10,900,000 | $25,500,237 | $-219,300,753 |
| Sale Of Business | $159,300,000 | $11,800,000 | - | - |
| Net Intangibles Purchase And Sale | $-21,500,000 | $-26,700,000 | $-17,447,531 | $-22,723,377 |
| Purchase Of Intangibles | $-21,500,000 | $-26,700,000 | $-17,447,531 | $-22,723,377 |
| Net PPE Purchase And Sale | $-337,500,000 | $-248,600,000 | $-366,666,573 | $-127,331,584 |
| Sale Of PPE | $800,000 | $500,000 | $3,757,930 | $16,672,773 |
| Purchase Of PPE | $-338,300,000 | $-249,100,000 | $-370,424,502 | $-144,004,357 |
| Taxes Refund Paid | $-300,200,000 | $-106,000,000 | $-122,132,716 | $-84,305,072 |
| Interest Paid Cfo | $-50,900,000 | $-10,800,000 | $-17,581,743 | $-6,991,808 |
| Change In Working Capital | $271,000,000 | $-22,300,000 | $-78,245,466 | $-82,288,204 |
| Change In Payable | $158,800,000 | $-17,100,000 | $71,669,089 | $69,649,166 |
| Change In Inventory | $153,800,000 | $18,500,000 | $-105,624,668 | $-74,758,564 |
| Change In Receivables | $-41,600,000 | $-23,700,000 | $-44,289,886 | $-77,178,806 |
| Other Non Cash Items | $49,500,000 | $11,100,000 | $-7,381,648 | $4,571,567 |
| Stock Based Compensation | $28,800,000 | $20,300,000 | $17,044,896 | $10,487,712 |
| Provisionand Write Offof Assets | $10,100,000 | $2,800,000 | $-3,892,142 | $-5,378,314 |
| Deferred Tax | $111,300,000 | $116,800,000 | $116,764,245 | $104,742,665 |
| Depreciation And Amortization | $544,100,000 | $186,400,000 | $195,546,558 | $184,745,085 |
| Amortization Cash Flow | $304,800,000 | $40,300,000 | $50,866,263 | $45,446,753 |
| Depreciation | $239,300,000 | $146,100,000 | $144,680,295 | $139,298,332 |
| Gain Loss On Investment Securities | $6,100,000 | $-20,100,000 | $-36,639,815 | $-11,966,749 |
| Net Foreign Currency Exchange Gain Loss | $7,900,000 | $-18,800,000 | $9,394,824 | $9,815,423 |
| Gain Loss On Sale Of Business | $-20,400,000 | $-11,800,000 | $-35,834,544 | $0 |
| Net Income From Continuing Operations | $305,800,000 | $407,900,000 | $494,704,607 | $422,869,937 |
| Common Stock Payments | - | $0 | $-67,105,888 | $-201,686,775 |
| Net Short Term Debt Issuance | - | $-8,730,483 | $25,902,873 | $42,085,307 |
| Purchase Of Business | - | $-22,700,000 | - | $-219,300,753 |
| Sale Of Intangibles | - | $134,315 | $0 | - |
| Interest Received Cfo | - | $10,342,265 | $2,415,812 | $2,420,241 |
| Gain Loss On Sale Of PPE | - | - | $0 | $-7,664,097 |
Fetched: 2026-02-02